Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Certain alkaloids could help create new coronavirus drugs.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

MR antagonists may improve skin health and wound healing, especially in aging.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Neurosteroids and benzodiazepines reduce neuron excitability, with lasting effects on inhibitory neurons.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.